TP53 and neoplasm: In particular, these guidelines take into account the diversity of clinical presentations associated with germline TP53 variants, the variability of the TP53 variant penetrance, the role of radiotherapy and chemotherapy in the development of subsequent primary tumour and the medical benefit of surveillance protocols.